scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.1016/J.OPHTHA.2012.11.042 |
P698 | PubMed publication ID | 23453513 |
P2093 | author name string | Howard Shapiro | |
David V Weinberg | |||
Jason S Ehrlich | |||
P433 | issue | 6 | |
P921 | main subject | phase III clinical trial | Q42824827 |
data analysis | Q1988917 | ||
P304 | page(s) | 1278-1282 | |
P577 | publication date | 2013-02-28 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | Ranibizumab treatment outcomes in phakic versus pseudophakic eyes: an individual patient data analysis of 2 phase 3 trials | |
P478 | volume | 120 |
Q24194251 | Anti-vascular endothelial growth factor for neovascular age-related macular degeneration |
Q92133213 | Anti-vascular endothelial growth factor for neovascular age-related macular degeneration |
Q35806580 | Comparison of intravitreal ranibizumab between phakic and pseudophakic neovascular age-related macular degeneration patients: Two-year results |
Q33900514 | Comparison of vitrectomized with nonvitrectomized eyes after subtenon injection of triamcinolone acetonide to treat diabetic macular edema: Retrospective comparative Analysis of an interventional case series. |
Q34610139 | Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain |
Q55312597 | Intravitreal Bevacizumab with or without Triamcinolone for Wet Age-related Macular Degeneration: Twelve-month Results of a Prospective, Randomized Investigation. |
Search more.